The US FDA is investigating the safety risks of CAR-T cancer treatment

The US Food and Drug Administration said it is investigating cancer treatments developed by Gilead Sciences, Johnson & Johnson, Novartis and others because of the risk of hospitalisation and death due to a serious safety issue.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM